−£4.52m
vs May 2024Active10014835Private limited companyLondon
REGENERUS RESEARCH LIMITED
Significant control: Regenerus Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Regenerus Research Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Regenerus Research Limited sell?
Registered activity: Other human health activities (SIC 86900). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
REGENERUS RESEARCH LIMITED is an active private limited company (company number 10014835) incorporated on 19 February 2016, registered in London. Its registered activity is other human health activities (SIC 86900). Latest small accounts cover the period ending 31 May 2025, showing net assets of −£4.52m and cash of £7,180, with 26 employees on average. Net assets fell 56% on the prior period (−£2.90m).
Peer position · net assets
By net assets it sits in the bottom quarter of 8,029 comparable companies in London (median £1,318, upper quartile £16k).
02
Ownership and control
- Regenerus Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- Mr Thomas Olivier Jaworski
- owns 50–75% of shares
- holds 50–75% of voting rights
- Mr Kenneth Muir Mcgrigor
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 19 February 201610 yrs ago
- Next accounts due
- 28 February 2027in 122 days
- Confirmation statement due
- 5 March 2027in 127 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 86900
- Other human health activities
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£7,180
−85%vs May 2024Not reported
26
+63%vs May 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | −£4.52m | £7,180 | £93k | — | — | — | 26 |
| 31 May 2024 | −£2.90m | £47k | £231k | — | — | — | 16 |
Cash per employee£276Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-4,518,957 at 31 May 2025
- Net assets down 25% or more on the prior period-55.8% vs prior period
- Incorporated five or more years agoIncorporated 19 February 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 127 days
- Next accounts duein 122 days
- Accounts period endNet liabilities £4.52m · small accounts
- Accounts period endNet liabilities £2.90m · small accounts
- Incorporated
08
Similar companies in London
- RARESPECIEZ LTDLondon · inc. Feb 2016
- REALIGNMENT THERAPY LIMITEDLondon · inc. Feb 2016
- PHYSICAL HEALTH CLINIC LTDLondon · inc. Feb 2016
- SUMMIT WELLBEING HEALTHCARE LTDLondon · inc. Feb 2016
- GENESIS NEW WORLD LIMITEDFulham · inc. Feb 2016
- INNER WISDOM LIMITEDLondon · inc. Feb 2016
All companies incorporated on 19 February 2016 · in Feb 2016.
09
Reminders for REGENERUS RESEARCH LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.